Abstract
BackgroundIt is well established that many gastroesophageal (GE) cancers are immune-sensitive. Programmed death ligand-1 (PD-L1) expression may have a predictive value in GE cancers. PD-L1/PD-1 inhibitors have profoundly influenced the...
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have